Document Type: Original Article


1 Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

3 fajr Milk, Industry Co., Golestan Sabah, Sabah, Gonbad, Iran

4 Department of Mycology, Fac of Vet. Med, Science and Research Branch Of Islamic Azad University, Tehran, Iran

5 Department of biotechnology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Iran



Human T-cell lymphotropic virus type 1 , 2 (HTLV-1, 2) is endemic in Particular Areas of the world in which it is associated with myeloid leukemia.In this study, we described the prevalence of HTLV-1, 2 in myeloid leukemia and Mycobacterium Tuberculosis in Iran. We have worked with tissue and blood samples for 2 years. These were the same samples which were positive for myeloid leukemia, Mycobacterium tuberculosis,HTLV and were collected from Imam Khomeini hospital in Tehran, Iran. 100 cases were investigated (58% males, 42% females), the age of these samples were within 5 to 89 years old.In 65.7 percent of the leukemia rate HTLV-1 has been positive. Five cases (54%) were myeloid leukemia, 36.4% cases were not myeloid leukemia and 3 out of 8 cases (27.9%) unclassified lymphomas, were positive respectively. All 6 cases (100%) were adults with acute T-cell leukemia/lymphoma (ATLL) and Mycobacterium tuberculosis were positive. Among all cases, just one case has been positive for chronic myeloid leukemia and myeloproliferative disruption. Positive HTLV-1- show more in older ages than younger one. At younger ages offers less than negative items. According to our results, in Iran HTLV-1, 2 is dramatically related to myeloid leukemia, and more studies are required for accurate connection with myeloma diseases and this area.


Main Subjects

Altafulla, M., De Bernal, J., Espino, H., Rios, B., 1989. Human T-cell Leukemia Virus-/and Hematologic Malignancies in Panama. Canc., 63, 2186-91.
Andrada‐Serpa, M.J., Tosswill, J., Schor, D., Linhares, D., Dobbin, J., Pereira, M.S., 1989. Seroepidemiologic survey for antibodies to human retroviruses in human and non‐human primates in Brazil. Int. J. Canc., 44(3), 389-93.

Araújo, A.P., Fontenelle, L.M., Pádua, P.A., Maia, Filho, H.S., De, Q.C., Araújo, A., 2002. Juvenile human T lymphotropic virus type 1-associated myelopathy. Clin. Infect. Dis., 35(2), 201-4.
Bartman, M.T., Kaidarova, Z., Hirschkorn, D., Sacher, R.A., Fridey, J., Garratty, G., 2008. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood., 112(10), 3995-4002.
Beilke, M.A., Theall, K.P., Clayton, J.L., Benjamin, S.M., Winsor, E.L., Kissinger, P.J., 2004. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin.
Infect. Dis., 39(2), 256-63.
Clark, J.W., Robert-Guroff, M., Ikehara, O., Henzan, E., Blattner, W.A., 1985. Human T-cell leukemia-lymphoma virus type 1 and adult T-cell leukemia-lymphoma in Okinawa. Canc. Res., 45(6), 2849-52.
Delacrétaz, F., Perey, L., Schmidt, P.M., Chave, J.P., Costa, J., 1987. Histopathology of bone marrow in human immunodeficiency virus infection. Virchows Archiv A., 411(6), 543-51.
Edlich, R., Hill, L.G., Williams, F.M., 2003. Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): an update. J. long. Term. Eff. Med. Implants., 13(2).
Einsiedel, L., Fernandes, L., Spelman, T., Steinfort, D., Gotuzzo, E., 2011. Bronchiectasis is associated with human Tlymphotropic virus 1 infection in an Indigenous Australian population. Clin. Infect. Dis., 766.
Garlet, G.P., Giozza, S.P., Silveira, E.M., Claudino, M., Santos, S.B., Avila-Campos, M.J., 2010. Association of human T lymphotropic virus 1 amplification of periodontitis severity with altered cytokine expression in response to
a standard periodontopathogen infection. Clin. Infect. Dis., 50(3), e11-e8.
Hayashi, S., Fine, R., Chou, T-C., Currens, M., Broder, S., Mitsuya, H., 1990. In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides
and virus-binding inhibitors. Antimicrobial agents and chemotherapy., 34(1), 82-8.
Henry, L., Carillo, S., Jourdan, E., Arnaud, A., Brun, S., Lavabre‐Bertrand, T., 2007. Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment. Am. J. Hematol., 82(6), 500-1.
Laurian, Y., Le Bras, P., Ellrodt, A., Alvin, P., 1986. Immune Thrombocytopenia Gammaglobulin, and Seropositivity to the Human T-Lymphotropic Virus Type III. Ann. Inter. Med., 105(1), 145-6.
Manns, A., Hisada, M., La Grenade, L., 1999. Human T-lymphotropic virus type I infection. The Lancet., 353(9168),1951-8.
Mori, N., Yamada, Y., Ikeda, S., Yamasaki, Y., Tsukasaki, K., Tanaka, Y., 2002. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I–infected T-cell lines and primary adult T-cell leukemia cells.
Blood., 100(5), 1828-34.
Olière, S., Douville, R., Sze, A., Belgnaoui, S.M., Hiscott, J., 2011. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis. Cytokine & growth factor reviews., 22(4), 197-210.
Sarvi, F., Momenian, S., Khodadost, M., Pahlavanzadeh, B., Nasehi, M., Sekhavati, E., 2016. The examination of relationship between socioeconomic factors and number of tuberculosis using quantile regression model for
count data in Iran 2010-2011. Med J Islam Repub Iran. Vol. 30:399.
Schuurman, H., Krone, W., Broekhuizen, R., Van Baarlen, J., Van Veen, P., Golstein, A., 1989. The thymus in acquired immune deficiency syndrome. Comparison with other types of immunodeficiency diseases, and
presence of components of human immunodeficiency virus type 1. Am. J. Pathol., 134(6), 1329.
Scoazec, J., Marche, C., Girard, P., Houtmann, J., Durand-Schneider, A., Saimot, A., 1988. Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV). An ultrastructural study. Am.
J. Pathol., 131(1), 38.
Sharief, M.K., Hentges, R., 1991. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. New England. J. Med., 325(7), 467-72.
Stahl-Hennig, C., Eisenblätter, M., Jasny, E., Rzehak, T., Tenner-Racz, K., Trumpfheller, C., 2009. Synthetic doublestranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human
papillomavirus in rhesus macaques. PLoS Pathog., 5(4), e1000373.
Starkebaum, G., Kalyanaraman, V., Kidd, P., Loughran, T., Kadin, M., Singer, J., 1987. Serum reactivity to human Tcell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. The
Lancet., 329(8533), 596-9.
Tang, S.W., Ducroux, A., Jeang, K.T., Neuveut, C., 2012. Impact of cellular autophagy on viruses: Insights from hepatitis B virus and human retroviruses. J. Biomed. Sci., 19(92), 10.1186.

Zeeb, H., Blettner, M., 1998. Adult leukaemia: what is the role of currently known risk factors? Radiation and environmental biophysics. 36(4), 217-28.
Zhang, Y., Nakata, K., Weiden, M., Rom, W.N., 1995. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J. Clin. Investig., 95(5), 2324.